Delivery Order SPE2DB24D3013-SPE2DB25FFKWA

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $5,350.72 and is a firm fixed-price delivery order, with an ultimate completion date of April 30, 2025. The contract is not set aside for any specific type of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $1,638.00 and is a firm fixed-price contract with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a firm fixed price, with a ceiling value of $20,037.66, and an ultimate completion date of May 2, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablet 60s, a medication used to treat and prevent blood clots. The contract has a ceiling value of $10,603.32 and is a firm fixed-price contract with an ultimate completion date of April 29, 2025. This award is not a set-aside contract, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Eliquis 2.5 mg tablets, a medication used for the treatment of various cardiovascular conditions. The contract has a ceiling value of $8,558.40 and an ultimate completion date of January 7, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has a total ceiling value of $3,931.20 and a period of performance ending on April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Eliquis 5 mg tablets, a medication used for cardiovascular health. The contract has a ceiling value of $16,306.67 and a period of performance through February 5, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $3,168.93 and a period of performance ending on April 30, 2025. It is a firm-fixed-price contract, which indicates the price for the medication is pre-determined. The contract is not set aside for any...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a ceiling value of $31,835.29 and a period of performance ending on April 28, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a total ceiling value of $17,025.32 and a period of performance through April 9, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition....
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFKWA
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 2.5 mg tablets, a medication used to reduce the risk of stroke and blood clots. The contract has a ceiling value of $1,474.20 and a period of performance through April 14, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/11/25, 9:45 AM